Westwood Management Corp IL cut its stake in shares of CVS Health Corporation (NYSE:CVS) by 78.6% during the second quarter, Holdings Channel reports. The firm owned 7,400 shares of the pharmacy operator’s stock after selling 27,200 shares during the period. Westwood Management Corp IL’s holdings in CVS Health Corporation were worth $708,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Springbok Capital Management LLC boosted its stake in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock valued at $117,000 after buying an additional 741 shares in the last quarter. Arcadia Investment Management Corp MI boosted its stake in CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock valued at $154,000 after buying an additional 750 shares in the last quarter. Physicians Financial Services Inc. boosted its stake in CVS Health Corporation by 5.8% in the second quarter. Physicians Financial Services Inc. now owns 1,849 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 101 shares in the last quarter. Highland Private Wealth Management acquired a new stake in CVS Health Corporation during the first quarter valued at approximately $198,000. Finally, Integrated Investment Consultants LLC boosted its stake in CVS Health Corporation by 13.8% in the second quarter. Integrated Investment Consultants LLC now owns 2,311 shares of the pharmacy operator’s stock valued at $221,000 after buying an additional 280 shares in the last quarter. Institutional investors own 81.08% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.03% on Friday, hitting $90.12. The company’s stock had a trading volume of 6,406,845 shares. The stock’s 50 day moving average price is $95.13 and its 200 day moving average price is $98.29. CVS Health Corporation has a 52 week low of $86.50 and a 52 week high of $106.67. The stock has a market capitalization of $96.09 billion, a P/E ratio of 20.73 and a beta of 0.84.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The company earned $43.70 billion during the quarter, compared to the consensus estimate of $44.28 billion. During the same quarter in the prior year, the firm earned $1.19 EPS. The company’s quarterly revenue was up 17.6% compared to the same quarter last year. On average, analysts forecast that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

CVS has been the subject of several recent analyst reports. Credit Suisse Group AG reissued a “buy” rating and issued a $115.00 price target on shares of CVS Health Corporation in a report on Sunday, June 5th. Morgan Stanley reissued a “hold” rating and issued a $104.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Jefferies Group reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. FBR & Co reissued an “outperform” rating and issued a $120.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Deutsche Bank AG raised their price target on CVS Health Corporation from $99.00 to $108.00 and gave the company a “hold” rating in a report on Wednesday, August 3rd. Six investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and a consensus price target of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.